A phase II study of apatinib on reversing resistance of paclitaxel-containing regimens in advanced gastric cancer (AGC).

被引：0
|
作者：
Lin, Rongbo [1 ]
Li, Hui [1 ]
Liu, Jie [1 ]
Zhao, Shen [1 ]
Yu, Jiaqing [1 ]
Fan, Nanfeng [1 ]
机构：
[1] Fujian Med Univ, Canc Hosp, Fujian Canc Hosp, Dept Gastrointestinal Med Oncol, Fuzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e16055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16055
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    H J Kang
    H M Chang
    T W Kim
    M-H Ryu
    H-J Sohn
    J H Yook
    S T Oh
    B S Kim
    J-S Lee
    Y-K Kang
    British Journal of Cancer, 2008, 98 : 316 - 322
  • [32] Phase II study of preoperative chemotherapy with paclitaxel (PTX) plus cisplatin (CDDP) for advanced gastric cancer
    Nagata, N.
    Tsuburaya, A.
    Cho, H.
    Hirabayashi, N.
    Kobayashi, M.
    Matsui, T.
    Munakata, Y.
    Kameda, Y.
    Oba, K.
    Sakamoto, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 370 - 370
  • [33] Phase II of epirubicin, cisplatin and modulated oral tegafur (EPT) in advanced gastric cancer (AGC)
    Gallardo, Enrique
    Batiste-Alentorn, Eduard
    Escudero, Pilar
    Alfaro, Jordi
    Pericay, Carles
    Losa, Ferran
    Esquerdo, Gaspar
    Alonso, Vicente
    Gallen, Manuel
    Arroyo, Monica
    ANNALS OF ONCOLOGY, 2004, 15 : 239 - 239
  • [34] Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer
    Ettinger, DS
    SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (02) : 148 - 150
  • [35] Phase I/II study of docetaxel (DOC) and S-1 for patients (pts) with advanced gastric cancer (AGC).
    Hyodo, I
    Yamaguchi, K
    Koizumi, W
    Narahara, H
    Kato, T
    Akiya, T
    Sakata, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 323S - 323S
  • [36] Phase I study of apatinib plus POF (paclitaxel plus FOLFOX) in patients (pts) with treatment-naive advanced gastric cancer (TNAGC)
    Lin, R.
    Shen, Z.
    Nanfeng, F.
    Hui, L.
    Jie, L.
    Jiaqing, Y.
    Min, Z.
    ANNALS OF ONCOLOGY, 2020, 31 : S912 - S912
  • [37] Phase I study of apatinib combined with POF (paclitaxel plus FOLFOX) in patients (pts) with treatment-naive advanced gastric cancer (TNAGC)
    Lin, R.
    Zhao, S.
    Fan, N.
    Li, H.
    Liu, J.
    Yu, J.
    Zhao, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 311 - 311
  • [38] Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer
    Tsuburaya, Akira
    Nagata, Naoki
    Cho, Haruhiko
    Hirabayashi, Naoki
    Kobayashi, Michiya
    Kojima, Hiroshi
    Munakata, Yasuhiro
    Fukushima, Ryoji
    Kameda, Yoichi
    Shimoda, Tadakazu
    Oba, Koji
    Sakamoto, Junichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1309 - 1314
  • [39] Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer
    Akira Tsuburaya
    Naoki Nagata
    Haruhiko Cho
    Naoki Hirabayashi
    Michiya Kobayashi
    Hiroshi Kojima
    Yasuhiro Munakata
    Ryoji Fukushima
    Yoichi Kameda
    Tadakazu Shimoda
    Koji Oba
    Junichi Sakamoto
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1309 - 1314
  • [40] Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer
    Lissoni, A
    Zanetta, G
    Losa, G
    Gabriele, A
    Parma, G
    Mangioni, C
    ANNALS OF ONCOLOGY, 1996, 7 (08) : 861 - 863
12345